DrugAbuse Sciences SAS
New European patent granted for naltrexone
Published in Law and Health Weekly, May 1st, 2004
This patent, which was previously granted in the U.S., covers the composition of injectable naltrexone microspheres to reduce consumption of heroin and alcohol.
DrugAbuse Sciences holds an exclusive worldwide license from Southern Research Institute (Southern Research, Birmingham, Alabama, USA) to develop a long-acting version of Naltrexone based on these patents. DrugAbuse Sciences Naltrexone Depot product is currently evaluated in phase III...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Breast Cancer
Exposure to famine associated with increased cancer risk - Ciphergen Biosystems, Inc.
Data on disease-specific inflammatory diagnostics reported at cancer meeting - Cutting Edge Information
Blending of branded and generic pharmaceutical industries expected to continue - Gender Selection
Kits claim to help choose baby's sex - Gift Awards
Eli Lilly gives $6 million to group that sued a year ago - Healthcare Coverage
AmeriHealth New Jersey approved to offer Medicare drug-discount cards - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
